Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Specimen Handling 191 Magnetic Resonance Spectroscopy 141 Biopsy 102 pembrolizumab 82 Carboplatin 76 Cisplatin 68 Nivolumab 62 Radiotherapy 51 Paclitaxel 51 Gemcitabine 50 Cyclophosphamide 48 Dexamethasone 46 durvalumab 39 Radiation 39 atezolizumab 36 Pemetrexed 36 olaparib 34 Rituximab 34 venetoclax 33 Etoposide 33 Doxorubicin 32 Lenalidomide 31 X-Rays 30 Prednisone 30 Bevacizumab 30 Docetaxel 28 Disulfides 28 Immunoglobulin G 27 Vincristine 26 Ipilimumab 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × aumolertinib × 30 days × Clear all

NCT04841811 2026-05-22

APPROACH

Guangdong Association of Clinical Trials

Phase 3 Active not recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡